Tirzepatide
Introduction:
Tirzepatide, is a medication used for the treatment of type 2 diabetes.
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood sugar control. After a person has eaten, these hormones are secreted by cells of the intestines and in turn cause the secretion of insulin. Tirzepatide is a GIP-analogue which activates both the GLP-1 and GIP receptors, leading to improved blood sugar control..
Tirzepatide is a glucose-dependent insulin-stimulating peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist that integrates the two insulin-stimulating effects into a single molecule. Through a dual mechanism of action to activate the hormone receptors involved in blood glucose control -GIP and GLP-1 two incretin receptors.
Product Name Tirzepatide Other Names LY3298176, GIP/GLP-1 RA CAS No. 2023788-19-2 Molecular formula C225H348N48O68 Molecular weight 4813.8 Storage 2~8°C Apperance White to off white powder or loose lump Purity ≧98.0%
Function:
1. Significantly reduce glycemic levels
2. Improve insulin sensitivity
3. Reducing body weight
4. Improving lipid metabolism
Our advantage:
About us
Company OverviewQuality ManagementResearch&DevelopmentCompany LeadershipProduct
Custom PeptideCosmetic PeptideSmall Molecular PeptideAmino AcidPersonal Care IngredientLyophilized PowderNews
Company News Industry NewsContact Information
CHINA
Company Tel: +86-+86-833-2598903 Tel: +86-+86 - 19162527690 Wechat: 19162527690 E-mail: Nyx-peptide@jsjpharm No.3 Jianye Avenue, High-tech Zone, Leshan, Sichuan, ChinaCopyright(C)2022, Sichuan Jisheng Biopharmaceutical Co.,Ltd All Rights Reserved.